Literature DB >> 20513292

[The establishment of a rapid fluorescent focus inhibition test for testing rabies virus neutralizing antibody].

Peng-cheng Yu1, Xin-jun Lv, Xin-xin Shen, Lei Cao, Xin-xiong Zheng, Hu Shan, Qing Tang.   

Abstract

OBJECTIVE: To establish a rapid fluorescent inhibition test (RFFIT) for testing rabies virus neutralizing antibody and the titer of rabies virus neutralizing antibody. CVS-11 was used as the standard challenge virus, and three generations prepared for the establishment of the virus library.
METHODS: International standard for rabies immunoglobulin was used as the reference serum. RFFIT test was established under consulting the protocol of Institute of Pasteur, and its specificity, stability and reproducibility were validated.
RESULTS: We established the RFFIT which showed both good specificity (100%) and reproducibility (P > 0.5).
CONCLUSION: The establishment of RFFIT test perfected the rabies laboratory techniques and would enhance the overall ability in detecting rabies in China.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20513292

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  3 in total

1.  Comparison of RFFIT tests with different standard sera and testing procedures.

Authors:  Peng-cheng Yu; Akira Noguchi; Satoshi Inoue; Qing Tang; Simon Rayner; Guo-dong Liang
Journal:  Virol Sin       Date:  2012-06-09       Impact factor: 4.327

2.  Making rabies prophylaxis more economical: immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers.

Authors:  Guihua Huang; Huazhang Liu; Qing Tang; Pengcheng Yu; Xinxin Shen; Yibin Zhang; Xiangyi Liu; Qing Cao; Chuanxi Fu; Beiyan Liu; Ming Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-05       Impact factor: 3.452

3.  Preparation and identification of anti-rabies virus monoclonal antibodies.

Authors:  Wen-juan Wang; Xiong Li; Li-hua Wang; Hu Shan; Lei Cao; Peng-cheng Yu; Qing Tang; Guo-dong Liang
Journal:  Virol Sin       Date:  2012-06-09       Impact factor: 4.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.